Anavex Life Sciences Corp (AVXL)

[BAR123]

We do not have to dilute (too much ). BIIB can buy shares at say $15pps for 5M new shares plus revenue sharing. BIIB handles all the development, manufacturing, etc and we get to share the rev. Maybe we get a deal worth high teens % on sales. Is that dilution?? I think not that bad. That gives us $75M and we now have a new level for our stock. That is for one indication, MS. We now will trade on the science so if we can get a deal like that add in the great news for alz, Parkinson's, Retts, etc we can get to a $50pps and a $2B market cap pretty quickly. Add in a partnership for Alz and Parkinson we are at $100 or a $4.5B market cap. Very realistic. Only one thing stopping us, does the drug work??